FDA cites 8 firms on illegal marketing of ibuprofen gels

08/20/2009 | Google

The FDA sent warning letters to eight companies that market topical ibuprofen products as a safer alternative to pain pills without submitting valid evidence to support that claim. Progressive Emu, one of the drugmakers, said it removed the claim from the label of its drug Emuprofen.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL